Aprindine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Aprindine is a Class 1b antiarrhythmic agent.[1]
In one study, it delayed atrial fibrillation more than digoxin did.[2]
It has shown effectiveness when given orally.[3]
References
References
- ↑ Sato R, Hisatome I, Tanaka Y; et al. (September 1991). “Aprindine blocks the sodium current in guinea-pig ventricular myocytes”. Naunyn Schmiedebergs Arch. Pharmacol. 344 (3): 331–6. doi:10.1007/bf00183008. PMID 1660104.
- ↑ Atarashi H, Inoue H, Fukunami M, Sugi K, Hamada C, Origasa H (June 2002). “Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation” (). Circ. J. 66 (6): 553–6. doi:10.1253/circj.66.553. PMID 12074271.
- ↑ Reid PR, Greene HL, Varghese PJ (December 1977). “Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome”. Br Heart J. 39 (12): 1353–60. doi:10.1136/hrt.39.12.1353. PMC 483421. PMID 603737.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH